How to Vet a GLP-1 Telehealth Provider: A 2026 Checklist
Dozens of sites now sell semaglutide and tirzepatide online. Some are careful, licensed operations. Others are one lawyer’s disclaimer away from a problem. Here’s exactly what to check before you hand over your health history and your credit card.
Before you start an intake with any GLP-1 provider, check for five things: a named pharmacy, a named and licensed medical team, LegitScript certification, transparent all-in pricing, and honest marketing claims. If a site is missing more than one of these, treat that as a reason to look elsewhere — not a technicality.
None of these checks require special expertise. Every one of them can be done in under five minutes on the provider’s own website, and most of what you need is either printed on the page or one click away in an FAQ.
Do they name their actual pharmacy?
This is the single biggest tell.
Compounded semaglutide and tirzepatide are prepared by licensed U.S. compounding pharmacies, not by the telehealth company itself. A provider that stands behind its product will name the pharmacy (or pharmacies) filling your prescription, usually with a phone number and website, so you can look up their state license and history directly.
A provider that never names a pharmacy anywhere on its site — not in the FAQ, not in the terms, not on request — is asking you to trust a supply chain you can’t see. That’s not automatically a scam, but it removes your ability to check, and in a category getting this much regulatory attention in 2026, that’s a real gap.
Is the medical team named and licensed?
Look for a real name, not a stock photo.
Legitimate telehealth providers name their prescribing physicians or medical group, and the better ones publish an NPI (National Provider Identifier) number you can look up in the federal NPPES registry to confirm the license is real and active. A named, board-certified physician with a public professional history is a meaningfully stronger signal than “our medical advisory board” with no names attached.
Are they LegitScript certified?
The industry’s baseline trust signal — but know what it does and doesn’t mean.
LegitScript certification has become close to a standard requirement for GLP-1 telehealth providers, and most legitimate operators display the badge (usually linked, so you can verify it directly on LegitScript’s own site rather than trusting an image). It confirms the company has passed a compliance review covering things like legitimate pharmacy relationships and advertising practices.
It is not, however, an FDA approval, and it doesn’t mean the specific compounded product you’re buying has been independently tested. Treat it as a floor, not a ceiling.
Is the pricing actually transparent?
Watch for the price that changes after month one.
“As low as $99/month” is a common headline in this category, and it’s often true only for a single starter month, a specific low dose, or a long-term prepaid bundle. Before you start an intake, look for the actual ongoing monthly cost at the dose you’d realistically need — not the lowest number on the page. Providers that disclose the full pricing table upfront, including any price increase after an introductory period, are being straight with you. Providers that only reveal the real number after you’ve started the intake are using the price as a hook.
Are their claims and reviews real?
Two things to watch for specifically.
First: compounded semaglutide and tirzepatide are not FDA-approved, and any provider that implies their compounded product is “the same as” or equivalent to an FDA-approved medication is making exactly the kind of claim the FDA sent 30 warning letters over in February 2026. A trustworthy provider says plainly that its compounded product is not FDA-approved and that a prescription isn’t guaranteed.
Second: some “independent reviews” of GLP-1 providers are written and distributed by the provider itself through a PR newswire, designed to look like third-party journalism. These often carry an “Advertorial” or “Sponsored” tag in the page’s own metadata, even when the headline reads like a neutral comparison. Worth a second look before treating any single glowing review as independent confirmation.